Eltrombopag Olamine Tablet, Film Coated
RxNorm Crosswalk NDC 42291-933

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Eltrombopag Olamine (NDC 42291-933) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 4 unique RxNorm concepts. By anchoring Avkare's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCD
Eltrombopag 12.5 mg Oral Tablet
SCD
Eltrombopag 25 mg Oral Tablet
SCD
Eltrombopag 50 mg Oral Tablet
SCD
Eltrombopag 75 mg Oral Tablet
SCDPrescribable
Featured Concept

eltrombopag 25 MG Oral Tablet
(RxCUI 825421)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
eltrombopag 25 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
eltrombopag (as eltrombopag olamine) 25 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

eltrombopag 50 MG Oral Tablet
(RxCUI 825427)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
eltrombopag 50 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
eltrombopag (as eltrombopag olamine) 50 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

eltrombopag 75 MG Oral Tablet
(RxCUI 884617)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
eltrombopag 75 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
eltrombopag (as eltrombopag olamine) 75 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

eltrombopag 12.5 MG Oral Tablet
(RxCUI 1245001)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
eltrombopag 12.5 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
eltrombopag (as eltrombopag olamine) 12.5 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.

Understanding RxNorm Mapping for Eltrombopag Olamine

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 42291-933 to RxCUI 1245001, 825421, 825427, 884617, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.